A phase II study of timed sequential therapy of acute myelogenous leukemia (AML) for patients over the age of 60: Two cycle timed sequential therapy with topotecan, ara-C and mitoxantrone in adults with poor-risk AML

Javier Bolaños-Meade, Chuanfa Guo, Ivana Gojo, Judith E. Karp

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of timed sequential therapy of acute myelogenous leukemia (AML) for patients over the age of 60: Two cycle timed sequential therapy with topotecan, ara-C and mitoxantrone in adults with poor-risk AML'. Together they form a unique fingerprint.

Medicine & Life Sciences